| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/24/2004 | CN1142911C Compounds with growth hormone releasing properties |
| 03/24/2004 | CN1142910C Amide compounds |
| 03/24/2004 | CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 03/24/2004 | CN1142792C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
| 03/24/2004 | CN1142779C Neovascularization promoters and neovascularization potentiators |
| 03/23/2004 | US6710209 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/23/2004 | US6710184 Crystalline solids of carvedilol and processes for their preparation |
| 03/23/2004 | US6710067 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/23/2004 | US6710058 Use as anticoagulant agents for therapy and prophylaxis ofthromboembolic disorders |
| 03/23/2004 | US6710057 Inhibitors of factor xa, as anticoagulants for prophylaxis and treatment of thromboembolic disorders |
| 03/23/2004 | US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii. |
| 03/23/2004 | US6710055 Indole and benzimidazole antithrombotic compounds, such as 1-methyl-2-(n-amidinophenyl)-aminomethyl)-5-(n-(hydroxycarbo quinoline-8-sulfonylamino)-indole |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6710048 Selective inhibitors of vascular endothelial growth factor receptor tyrosine kinase; to treat solid-tumor cancers, angiogenesis, diabetic retinopathy, rheumatoid arthritis, endometriosis and psoriasis |
| 03/23/2004 | US6710047 Phthalazines with angiogenesis inhibiting activity |
| 03/23/2004 | US6710044 Technical field |
| 03/23/2004 | US6710043 Possess the potentiation of the cholinergic activity |
| 03/23/2004 | US6710042 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 03/23/2004 | CA2307979C Novel production intermediate and process for producing pyridine derivative |
| 03/23/2004 | CA2307976C Novel production intermediate and process for producing pyridine derivative |
| 03/23/2004 | CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/23/2004 | CA2180535C A method for treatment of psoriasis, by omeprazole or related compounds |
| 03/18/2004 | WO2004022712A2 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE |
| 03/18/2004 | WO2004022553A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE |
| 03/18/2004 | WO2004022544A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 03/18/2004 | WO2004022542A2 Substituted 1,2,3,4-tetrahydroquinoline derivatives |
| 03/18/2004 | WO2004022540A2 Pyridazinone and pyridone derivatives as adenosine antagonists |
| 03/18/2004 | WO2004022539A1 Naphthyl ether compounds and their use |
| 03/18/2004 | WO2004022536A1 New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 03/18/2004 | WO2004022535A1 Acrylamide derivatives |
| 03/18/2004 | WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2004022055A1 1, 4, 5-substituted 1, 2-dihydro-pyrazol-3-one and 3-alkoxy-1h-pyrazole derivatives s tnf-alpha and interleukin lowering agents for the treatment of inflammations |
| 03/18/2004 | WO2004022041A2 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors |
| 03/18/2004 | WO2004012733A3 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 03/18/2004 | WO2004011453A3 Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles |
| 03/18/2004 | WO2004011447A3 Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine |
| 03/18/2004 | WO2004009583A3 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 03/18/2004 | WO2004009543A3 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors |
| 03/18/2004 | WO2004007459A3 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor |
| 03/18/2004 | WO2004006355A3 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 03/18/2004 | WO2004002983A3 Therapeutic piperazine derivatives useful for treating pain |
| 03/18/2004 | WO2003099266A3 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/18/2004 | WO2003097608A3 Opioid and opioid-like compounds and uses thereof |
| 03/18/2004 | WO2003094919A3 Novel crystalline forms of gatifloxacin |
| 03/18/2004 | WO2003066595A3 2 - piperazine - pyridines useful for treating pain |
| 03/18/2004 | WO2003047499A3 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 03/18/2004 | WO2003035615A3 Tyrosine kinase inhibitors |
| 03/18/2004 | WO2003035009A3 Treatment of acute myeloid leukemia with indolinone compounds |
| 03/18/2004 | US20040054187 Therapeutic ureas |
| 03/18/2004 | US20040054180 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 03/18/2004 | US20040054173 Antiinflammatory agents; autoimmune disease; antiarthritic agents |
| 03/18/2004 | US20040053985 Such as 1-(1-cyclooctyl-3-((nitrooxy)methyl)pyrazol-5-yl)-4-(methylsulfonyl)benzene; for synthesis of nitric oxide/ endothelium-derived relaxing factor; antiinflammatory agents; kits |
| 03/18/2004 | US20040053971 A fluorinated compounds, microbiocides, synthesis with chemical intermediates, amidation, debromination, benzylation, oximination |
| 03/18/2004 | US20040053970 Emzyme inhibitors, a 4-pyridinyl-3-pyrazoles derivatives, treating animal having cancer, restenosis, psoriasis, endometriosis, atherosclerosis, ischemia, myocardial ischemic; a plant having yeast infection and viral infection |
| 03/18/2004 | US20040053969 Pyrazol derivatives, pest control agent comprising the same as active ingredient, and process for producing the same |
| 03/18/2004 | US20040053966 Chemical derivatives and their application as antitelomerase agent |
| 03/18/2004 | US20040053963 Urotensin-II receptor antagonists |
| 03/18/2004 | US20040053961 Excitatory amino acid receptor antagonists |
| 03/18/2004 | US20040053956 Isoquinoline derivatives useful in the treatment of cns disorders |
| 03/18/2004 | US20040053955 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 03/18/2004 | US20040053952 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 03/18/2004 | US20040053949 Protein kinase c inhibitors; antiinflammatory agents; immunosuppresants; antidiabetic agents; immunomodulators |
| 03/18/2004 | US20040053943 Novel compounds |
| 03/18/2004 | US20040053937 Pyrimidine compounds |
| 03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
| 03/18/2004 | US20040053928 Quinoline derivatives as antibacterials |
| 03/18/2004 | US20040053926 Triazine compounds |
| 03/18/2004 | US20040053914 Substituted piperzino-pyridine compound, useful for treting pain, anxiety, urinary incontinence, an addictive disorder, Parkinson's disease, epilepsy, psychosis, and used as Selective antagonists of the metabotropic glutamate receptor 5 |
| 03/18/2004 | US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 03/18/2004 | US20040053907 Cell adhesion inhibitors |
| 03/18/2004 | DE10242350A1 New 3-aminomethylene-indoline-2-(thi)one derivatives, are kinase inhibitors useful for treating proliferative diseases e.g. tumors, rheumatoid arthritis, neovascular glaucoma and arteriosclerosis |
| 03/18/2004 | DE10241407A1 Behandlung nicht allergischer Rhinitis durch selektive Phosphodiesterase 4-Hemmstoffe Treatment not allergic rhinitis by selective phosphodiesterase 4 inhibitors |
| 03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | CA2497408A1 Indole-type derivatives as inhibitors of p38 kinase |
| 03/18/2004 | CA2497374A1 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors |
| 03/18/2004 | CA2497007A1 1, 4, 5-substituted 1, 2-dihydro-pyrazol-3-one and 3-alkoxy-1h-pyrazole derivatives s tnf-alpha and interleukin lowering agents for the treatment of inflammations |
| 03/18/2004 | CA2495939A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | CA2495284A1 Diarylurea derivatives and their use as chloride channel blockers |
| 03/17/2004 | EP1398033A2 Use of benzodiazepines for treating autoimmune diseases, inflammations, neoplasies, viral infections and atherosclerosis |
| 03/17/2004 | EP1398032A1 4-Oxo-quinazolines as LXR nuclear receptor binding compounds |
| 03/17/2004 | EP1398028A2 Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 03/17/2004 | EP1397678A1 Luciferin hydrazides |
| 03/17/2004 | EP1397488A1 Novel compounds for chemiluminescense procedures |
| 03/17/2004 | EP1397364A1 Novel pyrrole derivatives as pharmaceutical agents |
| 03/17/2004 | EP1397355A1 Pyridyl cyanoguanidine compounds |
| 03/17/2004 | EP1397354A1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors |
| 03/17/2004 | EP1397351A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 03/17/2004 | EP1397350A1 Isoquinolinone derivatives as parp inhibitors |
| 03/17/2004 | EP1397348A2 Factor xa inhibitor |
| 03/17/2004 | EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1242406B1 Novel compounds |
| 03/17/2004 | EP1224175B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 03/17/2004 | EP1186596B1 Process for the production of 2-pyridylpyridine derivatives |
| 03/17/2004 | EP1140839B1 Heterocyclic amides as inhibitors of factor xa |
| 03/17/2004 | EP0971588B1 Novel cannabinoid receptor modulators |
| 03/17/2004 | EP0891332B1 6-phenylpyridyl-2-amine derivatives |
| 03/17/2004 | CN1483031A Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them |
| 03/17/2004 | CN1483030A Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders |